Scholarships are available for promising and cover 50% of the course fee for the complete blended Clinical Development, the online Intellectual Property course and our brand new online Market Approval course. The scholarship does not include travel and lodging costs.


You are eligible for a scholarship if:

  • You are a graduated physician-investigator or biomedical scientist and;
  • You are employed at Netherlands Cancer Institute (NKI/AVL) or a University or University Medical Center or hospital in the Netherlands.


Please send your cv including your publication list and a brief motivation by email to  We will respond quickly to let you know if we still have scholarships available.

Online Market Approval course

Obtaining market approval is an important step in the development of a new biomedical product. In this course, you’ll learn how to find and interpret the relevant regulatory guidelines that will steer you through the development process. Real-world case studies, including the development of a gene therapy product and a fictitious mRNA-based vaccine, are presented to familiarize you with issues that can arise during development, as well as how to assess an Investigational Medicinal Product Dossier (IMPD).

Online Intellectual Property course

In this online learning-by-doing course you will learn the pros and cons of patent protection and how to protect your biomedical invention in a timely and optimally manner. In addition, you will learn the interplay between patent law and market exclusivity for medicinal products granted by regulatory agencies such as the FDA and EMA.

Blended Clinical Development course

The 3-part Clinical Development course introduces the Question-Based Clinical Development approach to define the most optimal development pathway for new medical interventions (online course with exam) and offers participants a unique opportunity to work on extensive teaching cases based on real R&D projects in interdisciplinary groups (on-campus course). Finally, a mentor coaches participants on how to write a ready-to-submit clinical trial application (on-campus extended course). Seating is limited (max 25 participants per course) to ensure the highest quality and enable intensive interactions.

Paul Janssen Futurelab